ClinicalTrials.gg
RecruitingNCT07887269NUS HealthUpdated Oct 21, 2026

NUS Health Study: Improving Sleep, Sedentariness and Physical Activity in NUS Staff

An interventional study of NUS Health Prog in Focused Strategies to Optimize Sleep, Reduce Sedentary Behaviour, and Enhance Incidental Physical Activity, sponsored by National University of Singapore. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by National University of Singapore · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
2,000
Allocation
Not applicable
Ages
21 Years to 70 Years
Sex
All
01

Study summary

'NUS Health' is a workplace-embedded health program for National University of Singapore (NUS) staff that concurrently targets sleep, sedentary behaviour, and physical activity. The intervention adopts a multilevel socioecological approach, integrating individual, social, environmental, and organisational strategies to support sustainable behaviour change.

The study team will evaluate the feasibility, acceptability, and effectiveness of this program in improving sleep and movement behaviours, with anticipated downstream benefits for cardiometabolic health, psychological well-being, and workplace productivity. Findings from this study will inform the development of future institution-wide health initiatives and contribute to the evidence base for integrated workplace interventions targeting multiple lifestyle risk factors simultaneously.

Read the detailed description

'NUS Health' is a workplace-embedded health program for National University of Singapore (NUS) staff that concurrently targets sleep, sedentary behaviour, and physical activity. The intervention adopts a multilevel socioecological approach, integrating individual, social, environmental, and organisational strategies to support sustainable behaviour change.

This program was developed in response to findings from our previous study of NUS staff which revealed high levels of sedentary behaviour (>10 hours/day) and an obesity prevalence of approximately 25%, highlighting a substantial opportunity for workplace-based health promotion. These findings emerged alongside the growing national burden of chronic conditions such as hypertension and type 2 diabetes, which are strongly influenced by modifiable lifestyle behaviours including insufficient sleep, prolonged sedentary behaviour, and inadequate physical activity. Although these behaviours frequently co-occur and interact to influence health outcomes, existing intervention approaches remain largely episodic, clinic-based, and focused on individual risk factors, limiting their scalability, sustainability, and effectiveness in real-world settings. Increasing evidence indicates that interventions addressing behavioural determinants across both individual and organisational levels are more likely to achieve meaningful and sustained improvements in health. Together, these considerations informed the development of a multicomponent, workplace-embedded intervention designed to simultaneously improve sleep, reduce sedentary behaviour, and promote physical activity among NUS staff.

By combining real-time behavioural monitoring, personalised digital feedback, social engagement, and organisational change, the program seeks to establish a scalable and sustainable model for workplace health promotion. Leveraging continuous wearable-derived data, participants will receive personalised behavioural targets and feedback based on their own activity and sleep patterns. These will be complemented by a socially oriented incentive framework and institution-wide health promotion strategies embedded within the workplace environment, enabling healthy behaviours to be supported not only at the individual level but also through organisational culture and practices.

This 16-month study will be divided into three distinct phases: baseline (months 1-4), intervention (months 5-10), and post-intervention (months 11-16). There will be 4 in-person visits in total for each participant: visit 1 (once within months 1-2), visit 2 (once within months 2-4), visit 3 (once within months 9-10) and visit 4 (once within months 15-16).

The study team will evaluate the feasibility, acceptability, and effectiveness of this program in improving sleep and movement behaviours, with anticipated downstream benefits for cardiometabolic health, psychological well-being, and workplace productivity.

Specifically, we will examine how changes in sleep, sedentariness, and physical activity, affect:

Sleep: frequency of short sleep nights, sleep onset time, sleep duration, sleep variability, sleep satisfaction Sendentariness: amount of sedentary time daily and its temporal distribution Physical activity: amount of daily light-intensity physical activity (LPA) and moderate-to-vigorous activity (MVPA) and its temporal distribution Cardiometabolic markers: glucose trends, blood pressure, body roundness index, blood markers of cardiometabolic health (e.g., blood lipids, Hba1c) Bio-aging markers: blood count, liver panel, renal panel, CRP, etc.

Findings from this study will inform the development of future institution-wide health initiatives and contribute to the evidence base for integrated workplace interventions targeting multiple lifestyle risk factors simultaneously.

02

Conditions studied

  • Focused Strategies to Optimize Sleep, Reduce Sedentary Behaviour, and Enhance Incidental Physical Activity

Browse trials for

Keywords

  • Sedentariness
  • Physical Activity
  • Sleep
  • Workplace Intervention
03

In context

Motor Activity

2,646 studies on the registry are indexed under Motor Activity; 1,205 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 60 across 2,309 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

National University of Singapore is the lead sponsor of 212 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Full time NUS staff
  • Willing to undergo blood draw procedure

Exclusion criteria

Exclusion Criteria:

  • Staff who tender their resignation from NUS during the 16-month study period will be discontinued from the study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
2,000 participants (estimated)

Study arms

  • Experimental
    Intervention

    The intervention involves the concurrent implementation of strategies to optimize sleep, reduce sedentary behaviour, and enhance incidental physical activity through an workplace embedded health promotion program. Participants will receive personalised goals and feedback based on their wearable-derived biometric data. An incentive system will be used to encourage engagement with the intervention and study procedures.

    Behavioral: NUS Health Prog

Interventions

  • BehavioralNUS Health Prog

    For the sleep component, personalised goals will focus on reducing or maintaining a low frequency of short sleep nights and, where appropriate, advancing sleep timing among individuals with delayed sleep schedules. Goals will be tailored to each participant using their biometric data. For the sedentariness component, personalised goals will focus on reducing daily sedentary time, with an overall target of approximately 8 hours per day or less. For the physical activity component, personalised goals will focus on increasing or maintaining moderate-to-vigorous physical activity (MVPA) levels.

06

What researchers measure

Primary outcomes

  1. Sendentariness, via OURA ring

    Amount of sedentary time daily, as measured by the OURA ring's sedentariness metric (energy expenditure of 1.5 metabolic equivalents (METs) or less ).

    Time frame: Through study completion, daily, an average of 2 years

  2. Moderate-to-vigorous activity (MVPA), via OURA ring

    Amount of daily moderate-to-vigorous activity (MVPA), as measured by the OURA ring.

    Time frame: Through study completion, daily, an average of 2 years

  3. Light-intensity physical activity (LPA), via OURA ring

    Amount of daily light-intensity physical activity (LPA), as measured by the OURA ring.

    Time frame: Through study completion, daily, an average of 2 years

  4. Sleep duration, via OURA ring

    Sleep duration as measured by the OURA ring.

    Time frame: Through study completion, daily, an average of 2 years

  5. Sleep duration variability

    The dispersion of daily sleep duration values around a participant's personal average.

    Time frame: Through study completion, an average of 2 years

  6. Sleep onset time, via OURA ring

    Sleep onset time as measured by the OURA ring.

    Time frame: Through study completion, daily, an average of 2 years

  7. Sleep onset variability

    The dispersion of daily sleep onset timing values around a participant's personal average.

    Time frame: Through study completion, an average of 2 years

  8. Glucose trends across 2 weeks

    Measured via Continuous Glucose Monitor

    Time frame: 2 weeks measurement period at baseline; subsequently at 9 months, and 15 months after baseline measurement

  9. Full blood count

    Measured via venous blood collection

    Time frame: At baseline; subsequently 9 months, and 15 months after baseline measurement

  10. Liver panel

    Measured via venous blood collection

    Time frame: At baseline; subsequently at 9 months, and 15 months after baseline measurement

  11. Renal panel

    Measured via venous blood collection

    Time frame: At baseline; subsequently at 9 months, and 15 months after baseline measurement

  12. Iron studies

    Measured via venous blood collection

    Time frame: At baseline; subsequently at 9 months, and 15 months after baseline measurement

  13. Urine panel

    Measured via urine collection

    Time frame: At baseline; subsequently at 9 months, and 15 months after baseline measurement

07

Study locations

1 of 1 sites recruiting
  • National University of Singapore
    Singapore, 117549, Singapore
    Recruiting
08

References and documents

Publications

  • Pereira MA, Mullane SL, Toledo MJL, Larouche ML, Rydell SA, Vuong B, Feltes LH, Mitchell NR, de Brito JN, Hasanaj K, Carlson NG, Gaesser GA, Crespo NC, Oakes JM, Buman MP. Efficacy of the 'Stand and Move at Work' multicomponent workplace intervention to reduce sedentary time and improve cardiometabolic risk: a group randomized clinical trial. Int J Behav Nutr Phys Act. 2020 Oct 27;17(1):133. doi: 10.1186/s12966-020-01033-3. PubMed 33109190 ↗

Related links

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07887269
Responsible party
Michael W.L. Chee (Professor Michael Chee Wei Liang, National University of Singapore) — Principal investigator
First posted
Oct 21, 2026
Start date
Sep 1, 2026
Primary completion
Jan 2029 (estimated)
Completion
Sep 2029 (estimated)
Last update
Oct 21, 2026

Study contacts

Michael Chee
Contact
michael.chee@nus.edu.sg
+65 66015238

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion